Tags: Cancer | chemo | nausea | rolapitant | cancer

New Help for Chemo Nausea

Wednesday, 02 September 2015 04:10 PM

The U.S. Food and Drug Administration approved Tesaro Inc's treatment for chemotherapy-induced nausea and vomiting in adults, the company said on Wednesday.

The drug, Rolapitant, was approved to be used along with other agents to prevent delayed nausea and vomiting associated with initial and repeat courses of chemotherapy, Tesaro said.

Tesaro licensed Rolapitant from Opko Health Inc in December 2010, giving it worldwide rights to develop and market the therapy.

© 2019 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
The U.S. Food and Drug Administration approved Tesaro Inc's treatment for chemotherapy-induced nausea and vomiting in adults, the company said on Wednesday. The drug, Rolapitant, was approved to be used along with other agents to prevent delayed nausea and vomiting...
chemo, nausea, rolapitant, cancer
70
2015-10-02
Wednesday, 02 September 2015 04:10 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved